CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 96 filers reported holding CYTOKINETICS INC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $290,000 | +19.8% | 20,000 | 0.0% | 0.04% | +12.9% |
| Q2 2017 | $242,000 | -5.8% | 20,000 | 0.0% | 0.03% | -8.8% |
| Q1 2017 | $257,000 | +5.8% | 20,000 | 0.0% | 0.03% | -15.0% |
| Q4 2016 | $243,000 | +32.1% | 20,000 | 0.0% | 0.04% | +21.2% |
| Q3 2016 | $184,000 | -3.2% | 20,000 | 0.0% | 0.03% | 0.0% |
| Q2 2016 | $190,000 | +34.8% | 20,000 | 0.0% | 0.03% | +17.9% |
| Q1 2016 | $141,000 | -32.5% | 20,000 | 0.0% | 0.03% | -36.4% |
| Q4 2015 | $209,000 | +56.0% | 20,000 | 0.0% | 0.04% | +46.7% |
| Q3 2015 | $134,000 | 0.0% | 20,000 | 0.0% | 0.03% | +11.1% |
| Q2 2015 | $134,000 | +97.1% | 20,000 | +100.0% | 0.03% | +107.7% |
| Q1 2015 | $68,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |